ICTD 2022 - Recruitment in Clinical Trials

ECRIN, together with our German national partner, the KKS Netzwerk, hosted International Clinical Trials Day 2022 as a hybrid event located in Berlin.

We are very proud to present to you the ECRIN Annual Report 2021! As you may notice right away, the Annual Report is presented to you in an entirely new format. Namely, the size changed from an A4 to a square format, so that it will better fit your screens.

In June 2022, after 42 months of extensive work from the 11 consortium partners, SYNCHROS (SYNergies for Cohorts in Health: integrating the Role of all Stakeholders) is coming to an end.

On June 16th and 17th the PERMIT project consortium, personalised medicine experts and other invested stakeholders met in Milan (and online) at the Istituto di Recherche Farmacologiche Mario Negri to discuss the recommendations that were developed over the 2.5 years of the project.

The SIMCor project is developing a computational platform for in-silico testing and validation of cardiovascular implantable devices. How this works?

The call for application to ECRIN Data Centre Certification Programme is open until the 23 September 2022.

ECRIN and its national partners are working on a training series that will focus on supporting researchers to develop proposals for European calls that are open to mult

ISIDORe just launched the first call for transnational access for projects focusing on SARS-CoV-2 and COVID-19 research. ISIDORe TNA programme aims at supporting scientists by providing them access (physical, remote, or virtual) to facilities, equipment, expertise, services and resources that the

TRANSVAC2, an European vaccine research and development (R&D) infrastructure project, is dedicated to accelerating the development of safe, effective and affordable vaccines.

ECRIN supports clinical trials across borders. How do we do that? We are very proud to show it to you in our brand new video!

The EU-SolidAct trial, previously authorized under the EU CT Directive 2001/20/EC, has been successfully transferred and is authorized under the new EU regulation (Regulation (EU) No 536/2014) in 12 countries.

After more than 2 years, our partner EUPATI organises the Fundamentals in a face to face session. EUPATI Fundamentals is a training about Patient Engagement addressed to professionals in academia and pharmaceutical industry.

The MACUSTAR project has received a second Letter of Support from the European Medicines Agency (EMA) for its work on new measures to assess the eye disease age-related macular degeneration in clinical trials.

EU-AMRI, the European Alliance of Medical Research Infrastructures, was officially launched during a live broadcast from Brussels on 5 April 2022.

International Clinical Trial Day 2022 will be co-hosted by ECRIN (European Clinical Research Infrastructure Network) and its German scientific partner KKS-Netzwerk (the Network of Coordinating Centres for Clinical Trials) on May 17th 2022, and this years’ theme is Recruitment in Clinical Trials.

On 17 March, the PERMIT project held its Implementation Workshop.

ISIDORe – “Integrated Services for Infectious Disease Outbreak Research” was officially launched on the 24 February 2022.

The PERMIT project hosted its 4th General Assembly on 4 February 2022. With the approval of the 6-month no-cost extension of the project, this meeting marks the beginning of the home stretch for the project. Each work package presented the actions carried out since July 2021.